SB 1458 Arizona Senate · 57th Legislature - Second Regular Session

pharmacy board; civil penalties

SB 1458 amends Arizona's Pharmacy Board authority under Section 32-1904. It updates the board's powers to require fingerprint clearance for pharmacy license applicants, clarify inspection procedures for facilities handling drugs, and establish rules for license reinstatement. The bill directly affects pharmacies, pharmacists, pharmacy technicians, and drug manufacturers by modifying licensing requirements, inspection protocols, and complaint handling. Key provisions include mandating fingerprint checks for new licenses (with limited exceptions for criminal history), enabling board access for facility inspections, and creating a process for issuing "certificate of free sale" for dietary supplements. The title referencing "civil penalties" does not align with the bill's actual content, which focuses on procedural and administrative changes to the board's operations.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2026

Committee Review

Feb 2026

Senate Passage

Mar 2026

House Passage

Governor

Introduced Jan 29, 2026 Last action Mar 23, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduced Version → Senate Engrossed Version (03/03/2026) · 7 edits · Mar 3, 2026

MODERATE

This bill significantly expands the Arizona State Board of Pharmacy's authority by adding new powers to approve pharmacy schools and training programs, grant exceptions for modernization, and issue certificates for food supplements. It also introduces a new system for issuing nondisciplinary civil penalties for administrative failures like late profile updates or missing continuing education, with a maximum penalty of $25,000 per six-month period. Additionally, the bill clarifies disciplinary procedures for permittees, including new options for interim consent agreements and formal hearings for violations.

Scope change

The bill expands the scope of the Board's regulatory authority to include oversight of pharmacy education programs and specific exemptions for technological advances, while also extending its enforcement reach to include administrative non-compliance.

REQUIREMENT

Added new powers for the Board to approve colleges of pharmacy, practical experience programs, and internship training programs.

Added authority for the Board to grant permission to deviate from state requirements for modernization, experimentation, or technological advances.

Added authority to issue certificates of free sale for food and dietary supplements manufactured by licensed manufacturers.

ENFORCEMENT

Created a new category of nondisciplinary civil penalties for administrative failures, such as failing to update online profiles or complete continuing education, with a cap of $25,000 every six months.

Added authority for the Executive Director to enter into interim consent agreements to mitigate public health dangers before a formal board decision.

Expanded the list of specific violations subject to nondisciplinary civil penalties, including failure to notify the board of criminal charges, disciplinary actions by other agencies, or license expiration.

DEFINITION

Added a new provision allowing the Board to exclude certain stimulant or depressant substances from the definition of dangerous drugs if they are mixed with non-stimulant ingredients.

Floor votes · Senate Mar 3, 2026

How they voted

29–1

Passed

Total votes 30

Mar 3, 2026

D Democratic13

13 Yea

100% Yea

R Republican17

16 Yea 1 Nay

94% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Mar 23, 2026

Lower · Passed

DPA/SE

lower

Mar 3, 2026

Upper · Passed

PASSED

upper

Feb 18, 2026

Upper · Passed

upper

1 primary · 0 co-sponsors